Latest stories on SRZN
Surrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Surrozen submits investigational new drug application for SZN-8141
The Fly63 · neutralproduct/pr
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
Business Insider63 · neutralproduct/pr
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
GlobeNewswire63 · neutralproduct/pr
Surrozen to Present at Upcoming Healthcare Investor Conferences
GlobeNewswire56 · neutralgeneral
Surrozen to Present at Upcoming Healthcare Investor Conferences
Business Insider56 · neutralproduct/pr
William Blair initiates Surrozen stock with Outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Surrozen initiated with an Outperform at William Blair
The Fly61 · neutralanalyst
H.C. Wainwright reiterates Surrozen stock rating at buy, $44 target
Investing.com Analyst Ratings61 · neutralanalyst
Surrozen GAAP EPS of -$0.41
Seeking Alpha34 · bearishearnings